Published in Cancer Epidemiol Biomarkers Prev on April 01, 2003
Using clinical factors and mammographic breast density to estimate breast cancer risk: development and validation of a new predictive model. Ann Intern Med (2008) 4.81
Risk factors for breast cancer for women aged 40 to 49 years: a systematic review and meta-analysis. Ann Intern Med (2012) 2.85
Mammographic density, breast cancer risk and risk prediction. Breast Cancer Res (2007) 2.71
Is breast cancer the same disease in Asian and Western countries? World J Surg (2010) 2.33
Mammographic density phenotypes and risk of breast cancer: a meta-analysis. J Natl Cancer Inst (2014) 2.10
Mammographic density reduction is a prognostic marker of response to adjuvant tamoxifen therapy in postmenopausal patients with breast cancer. J Clin Oncol (2013) 1.86
Relationship between mammographic density and breast cancer death in the Breast Cancer Surveillance Consortium. J Natl Cancer Inst (2012) 1.80
Greatly increased occurrence of breast cancers in areas of mammographically dense tissue. Breast Cancer Res (2005) 1.76
Texture features from mammographic images and risk of breast cancer. Cancer Epidemiol Biomarkers Prev (2009) 1.65
Nondense mammographic area and risk of breast cancer. Breast Cancer Res (2011) 1.45
MRI Background Parenchymal Enhancement Is Not Associated with Breast Cancer. PLoS One (2016) 1.44
Positive association between mammographic breast density and bone mineral density in the Postmenopausal Estrogen/Progestin Interventions Study. Breast Cancer Res (2005) 1.39
Percentage density, Wolfe's and Tabár's mammographic patterns: agreement and association with risk factors for breast cancer. Breast Cancer Res (2005) 1.37
Conjugated equine estrogen influence on mammographic density in postmenopausal women in a substudy of the women's health initiative randomized trial. J Clin Oncol (2009) 1.35
Automatic classification of mammography reports by BI-RADS breast tissue composition class. J Am Med Inform Assoc (2012) 1.35
An automated approach for estimation of breast density. Cancer Epidemiol Biomarkers Prev (2008) 1.35
Mammographic density and breast cancer risk: the role of the fat surrounding the fibroglandular tissue. Breast Cancer Res (2011) 1.33
Menstrual and reproductive factors in relation to mammographic density: the Study of Women's Health Across the Nation (SWAN). Breast Cancer Res Treat (2007) 1.29
Common breast cancer susceptibility variants in LSP1 and RAD51L1 are associated with mammographic density measures that predict breast cancer risk. Cancer Epidemiol Biomarkers Prev (2012) 1.26
The association of mammographic density with ductal carcinoma in situ of the breast: the Multiethnic Cohort. Breast Cancer Res (2006) 1.25
Oligogenic combinations associated with breast cancer risk in women under 53 years of age. Hum Genet (2004) 1.21
Association of mammographic density with the pathology of subsequent breast cancer among postmenopausal women. Cancer Epidemiol Biomarkers Prev (2008) 1.19
Breast percent density: estimation on digital mammograms and central tomosynthesis projections. Radiology (2009) 1.17
Reproductive and Hormonal Factors Associated with Fatty or Dense Breast Patterns among Korean Women. Cancer Res Treat (2011) 1.03
Visually assessed breast density, breast cancer risk and the importance of the craniocaudal view. Breast Cancer Res (2008) 1.03
Polymorphisms in a Putative Enhancer at the 10q21.2 Breast Cancer Risk Locus Regulate NRBF2 Expression. Am J Hum Genet (2015) 1.00
Interaction of dense breast patterns with other breast cancer risk factors in a case-control study. Br J Cancer (2004) 0.97
Mammographic density and hormone receptor expression in breast cancer: the Multiethnic Cohort Study. Cancer Epidemiol (2011) 0.97
Distribution of mammographic density and its influential factors among Chinese women. Int J Epidemiol (2014) 0.97
Age- and race-dependence of the fibroglandular breast density analyzed on 3D MRI. Med Phys (2010) 0.96
Mammographic density and breast cancer risk in White and African American Women. Breast Cancer Res Treat (2012) 0.96
Expression levels of uridine 5'-diphospho-glucuronosyltransferase genes in breast tissue from healthy women are associated with mammographic density. Breast Cancer Res (2010) 0.96
Mammographic density and risk of breast cancer by adiposity: an analysis of four case-control studies. Int J Cancer (2011) 0.95
Mammographic breast density--evidence for genetic correlations with established breast cancer risk factors. Cancer Epidemiol Biomarkers Prev (2008) 0.95
Green tea, soy, and mammographic density in Singapore Chinese women. Cancer Epidemiol Biomarkers Prev (2008) 0.94
Polymorphisms in genes involved in estrogen and progesterone metabolism and mammographic density changes in women randomized to postmenopausal hormone therapy: results from a pilot study. Breast Cancer Res (2005) 0.94
Adiposity, adult weight gain and mammographic breast density in US Chinese women. Int J Cancer (2010) 0.93
Predictors of mammographic density: insights gained from a novel regression analysis of a twin study. Cancer Epidemiol Biomarkers Prev (2008) 0.92
Mammographic density, parity and age at first birth, and risk of breast cancer: an analysis of four case-control studies. Breast Cancer Res Treat (2012) 0.92
Polymorphisms in hormone metabolism and growth factor genes and mammographic density in Norwegian postmenopausal hormone therapy users and non-users. Breast Cancer Res (2012) 0.92
Mammographic density and inter-observer variability of pathologic evaluation of core biopsies among women with mammographic abnormalities. BMC Cancer (2012) 0.92
Mammographic breast density and subsequent risk of breast cancer in postmenopausal women according to the time since the mammogram. Cancer Epidemiol Biomarkers Prev (2013) 0.91
Mammographic breast density and breast cancer risk by menopausal status, postmenopausal hormone use and a family history of breast cancer. Cancer Causes Control (2012) 0.89
Comparison of Clinical and Automated Breast Density Measurements: Implications for Risk Prediction and Supplemental Screening. Radiology (2015) 0.88
Breast cancer susceptibility loci and mammographic density. Breast Cancer Res (2008) 0.88
Adolescent lifestyle factors and adult breast density in U.S. Chinese immigrant women. Nutr Cancer (2011) 0.86
Activation of the mTOR pathway by low levels of xenoestrogens in breast epithelial cells from high-risk women. Carcinogenesis (2011) 0.86
Percent Mammographic Density and Dense Area as Risk Factors for Breast Cancer. Geburtshilfe Frauenheilkd (2012) 0.86
Relationship between breast cancer risk factors and mammographic breast density in the Fernald Community Cohort. Br J Cancer (2012) 0.86
International Consortium on Mammographic Density: Methodology and population diversity captured across 22 countries. Cancer Epidemiol (2015) 0.85
Age and ethnic differences in volumetric breast density in new zealand women: a cross-sectional study. PLoS One (2013) 0.85
Black breast cancer survivors experience greater upper extremity disability. Breast Cancer Res Treat (2015) 0.84
Mammographic density defined by higher than conventional brightness threshold better predicts breast cancer risk for full-field digital mammograms. Breast Cancer Res (2015) 0.83
Methods for assessing and representing mammographic density: an analysis of 4 case-control studies. Am J Epidemiol (2013) 0.83
The relation of urinary estrogen metabolites with mammographic densities in premenopausal women. Cancer Epidemiol (2012) 0.83
Mediterranean diet and breast density in the Minnesota Breast Cancer Family Study. Nutr Cancer (2008) 0.81
Association between mammographic density and basal-like and luminal A breast cancer subtypes. Breast Cancer Res (2013) 0.81
Higher alcohol intake may modify the association between mammographic density and breast cancer: an analysis of three case-control studies. Cancer Epidemiol (2012) 0.81
Quantitative assessment of breast mammographic density with a new objective method. J Med Life (2011) 0.81
Mammographic breast density and breast cancer risk: interactions of percent density, absolute dense, and non-dense areas with breast cancer risk factors. Breast Cancer Res Treat (2015) 0.81
No effect of aspirin on mammographic density in a randomized controlled clinical trial. Cancer Epidemiol Biomarkers Prev (2009) 0.81
The Minnesota Green Tea Trial (MGTT), a randomized controlled trial of the efficacy of green tea extract on biomarkers of breast cancer risk: study rationale, design, methods, and participant characteristics. Cancer Causes Control (2015) 0.81
Gene variations in oestrogen pathways, CYP19A1, daily 17β-estradiol and mammographic density phenotypes in premenopausal women. Breast Cancer Res (2014) 0.79
Cyclic endogenous estrogen and progesterone vary by mammographic density phenotypes in premenopausal women. Eur J Cancer Prev (2016) 0.79
Vitamin D intake, month the mammogram was taken and mammographic density in Norwegian women aged 50-69. PLoS One (2015) 0.79
Plasma levels of leptin and mammographic density among postmenopausal women: a cross-sectional study. Breast Cancer Res (2006) 0.79
High mammographic density in women of Ashkenazi Jewish descent. Breast Cancer Res (2013) 0.78
Mammographic density and breast cancer risk by family history in women of white and Asian ancestry. Cancer Causes Control (2015) 0.78
MARIA M4: clinical evaluation of a prototype ultrawideband radar scanner for breast cancer detection. J Med Imaging (Bellingham) (2016) 0.77
Plasma leptin levels, LEPR Q223R polymorphism and mammographic breast density: a cross-sectional study. Int J Biol Markers (2013) 0.77
Mammographic density is not a worthwhile examination to distinguish high cancer risk women in screening. Eur Radiol (2014) 0.77
Reproductive and lifestyle risk factors and mammographic density in Mexican women. Ann Epidemiol (2015) 0.76
Social inequalities in health in nonhuman primates. Neurobiol Stress (2014) 0.76
Mammographic Breast Density in Chinese Women: Spatial Distribution and Autocorrelation Patterns. PLoS One (2015) 0.76
Variation in inflammatory cytokine/growth-factor genes and mammographic density in premenopausal women aged 50-55. PLoS One (2013) 0.76
Insulin-like growth factor 1 receptor expression in breast cancer tissue and mammographic density. Mol Clin Oncol (2015) 0.76
Mammographic density and breast cancer: a comparison of related and unrelated controls in the Breast Cancer Family Registry. Breast Cancer Res (2013) 0.75
Adolescent fiber intake and mammographic breast density in premenopausal women. Breast Cancer Res (2016) 0.75
Breast Density and Risk of Breast Cancer in Asian Women: A Meta-analysis of Observational Studies. J Prev Med Public Health (2016) 0.75
A comprehensive evaluation of interaction between genetic variants and use of menopausal hormone therapy on mammographic density. Breast Cancer Res (2015) 0.75
Response of bilateral breasts to the endogenous hormonal fluctuation in a menstrual cycle evaluated using 3D MRI. Magn Reson Imaging (2012) 0.75
Polymorphisms in the estrogen receptor alpha gene (ESR1), daily cycling estrogen and mammographic density phenotypes. BMC Cancer (2016) 0.75
Evaluation of the association between quantitative mammographic density and breast cancer occurred in different quadrants. BMC Cancer (2017) 0.75
Volumetric breast ultrasound as a screening modality in mammographically dense breasts. ISRN Radiol (2012) 0.75
Alcohol intake from early adulthood to midlife and mammographic density. Cancer Causes Control (2016) 0.75
Breast density across a regional screening population: effects of age, ethnicity and deprivation. Br J Radiol (2015) 0.75
Breast cancer risk in rheumatoid arthritis: an update meta-analysis. Biomed Res Int (2014) 0.75
Qualitative Versus Quantitative Mammographic Breast Density Assessment: Applications for the US and Abroad. Diagnostics (Basel) (2017) 0.75
Multiple regions within 8q24 independently affect risk for prostate cancer. Nat Genet (2007) 14.37
Large-scale genotyping identifies 41 new loci associated with breast cancer risk. Nat Genet (2013) 8.24
Ethnic and racial differences in the smoking-related risk of lung cancer. N Engl J Med (2006) 7.82
A common genetic risk factor for colorectal and prostate cancer. Nat Genet (2007) 7.11
Epidemiologic evaluation of measurement data in the presence of detection limits. Environ Health Perspect (2004) 6.43
Choosing haplotype-tagging SNPS based on unphased genotype data using a preliminary sample of unrelated subjects with an example from the Multiethnic Cohort Study. Hum Hered (2003) 5.78
Association between endometriosis and risk of histological subtypes of ovarian cancer: a pooled analysis of case-control studies. Lancet Oncol (2012) 5.70
Oral contraceptives and the risk of breast cancer. N Engl J Med (2002) 4.85
Impact of socioeconomic status on cancer incidence and stage at diagnosis: selected findings from the surveillance, epidemiology, and end results: National Longitudinal Mortality Study. Cancer Causes Control (2008) 4.56
Common variants at 19p13 are associated with susceptibility to ovarian cancer. Nat Genet (2010) 4.51
A genome-wide association study identifies a new ovarian cancer susceptibility locus on 9p22.2. Nat Genet (2009) 4.38
Multiple independent variants at the TERT locus are associated with telomere length and risks of breast and ovarian cancer. Nat Genet (2013) 4.35
Projecting individualized absolute invasive breast cancer risk in African American women. J Natl Cancer Inst (2007) 3.93
A multi-stage genome-wide association study of bladder cancer identifies multiple susceptibility loci. Nat Genet (2010) 3.93
A genome-wide association study identifies susceptibility loci for ovarian cancer at 2q31 and 8q24. Nat Genet (2010) 3.86
Postmenopausal hormone therapy and change in mammographic density. J Natl Cancer Inst (2003) 3.83
Genome-wide association studies identify four ER negative-specific breast cancer risk loci. Nat Genet (2013) 3.81
Leisure time spent sitting in relation to total mortality in a prospective cohort of US adults. Am J Epidemiol (2010) 3.64
Reproductive factors and breast cancer risk according to joint estrogen and progesterone receptor status: a meta-analysis of epidemiological studies. Breast Cancer Res (2006) 3.62
Elevated biomarkers of inflammation are associated with reduced survival among breast cancer patients. J Clin Oncol (2009) 3.58
GWAS meta-analysis and replication identifies three new susceptibility loci for ovarian cancer. Nat Genet (2013) 3.42
Methods for pooling results of epidemiologic studies: the Pooling Project of Prospective Studies of Diet and Cancer. Am J Epidemiol (2006) 3.41
A common variant at the TERT-CLPTM1L locus is associated with estrogen receptor-negative breast cancer. Nat Genet (2011) 3.37
Variation of breast cancer risk among BRCA1/2 carriers. JAMA (2008) 3.30
Physical activity levels before and after a diagnosis of breast carcinoma: the Health, Eating, Activity, and Lifestyle (HEAL) study. Cancer (2003) 3.25
Genome-wide association analysis identifies three new breast cancer susceptibility loci. Nat Genet (2012) 3.20
A common 8q24 variant in prostate and breast cancer from a large nested case-control study. Cancer Res (2007) 3.08
The landscape of recombination in African Americans. Nature (2011) 3.06
Prevalence and predictors of BRCA1 and BRCA2 mutations in a population-based study of breast cancer in white and black American women ages 35 to 64 years. Cancer Res (2006) 3.06
Physical activity levels among breast cancer survivors. Med Sci Sports Exerc (2004) 2.88
Influence of pre- and postdiagnosis physical activity on mortality in breast cancer survivors: the health, eating, activity, and lifestyle study. J Clin Oncol (2008) 2.85
Diagnostic evaluation of HER-2 as a molecular target: an assessment of accuracy and reproducibility of laboratory testing in large, prospective, randomized clinical trials. Clin Cancer Res (2005) 2.85
Long-term exposure to constituents of fine particulate air pollution and mortality: results from the California Teachers Study. Environ Health Perspect (2009) 2.72
Evaluation of HER-2/neu gene amplification and overexpression: comparison of frequently used assay methods in a molecularly characterized cohort of breast cancer specimens. J Clin Oncol (2002) 2.67
Adiposity and sex hormones in postmenopausal breast cancer survivors. J Clin Oncol (2003) 2.65
Active smoking, household passive smoking, and breast cancer: evidence from the California Teachers Study. J Natl Cancer Inst (2004) 2.62
FGFR2 variants and breast cancer risk: fine-scale mapping using African American studies and analysis of chromatin conformation. Hum Mol Genet (2009) 2.62
National Institutes of Health State-of-the-Science Conference statement: Diagnosis and Management of Ductal Carcinoma In Situ September 22-24, 2009. J Natl Cancer Inst (2010) 2.59
Etiologic heterogeneity among non-Hodgkin lymphoma subtypes. Blood (2008) 2.49
Alteration of topoisomerase II-alpha gene in human breast cancer: association with responsiveness to anthracycline-based chemotherapy. J Clin Oncol (2010) 2.48
A meta-analysis of genome-wide association studies of breast cancer identifies two novel susceptibility loci at 6q14 and 20q11. Hum Mol Genet (2012) 2.45
Aspirin, nonaspirin nonsteroidal anti-inflammatory drug, and acetaminophen use and risk of invasive epithelial ovarian cancer: a pooled analysis in the Ovarian Cancer Association Consortium. J Natl Cancer Inst (2014) 2.40
Quality of race, Hispanic ethnicity, and immigrant status in population-based cancer registry data: implications for health disparity studies. Cancer Causes Control (2007) 2.36
Population-based case-control study of recreational drug use and testis cancer risk confirms an association between marijuana use and nonseminoma risk. Cancer (2012) 2.33
Alcohol consumption and risk of non-Hodgkin lymphoma: a pooled analysis. Lancet Oncol (2005) 2.27
Associations of insulin resistance and adiponectin with mortality in women with breast cancer. J Clin Oncol (2010) 2.26
Functional variants at the 11q13 risk locus for breast cancer regulate cyclin D1 expression through long-range enhancers. Am J Hum Genet (2013) 2.24
Long-term exposure to air pollution and cardiorespiratory disease in the California teachers study cohort. Am J Respir Crit Care Med (2011) 2.21
The NICHD Women's Contraceptive and Reproductive Experiences Study: methods and operational results. Ann Epidemiol (2002) 2.21
Obesity, recreational physical activity, and risk of pancreatic cancer in a large U.S. Cohort. Cancer Epidemiol Biomarkers Prev (2005) 2.16
Breast cancer risk factors defined by estrogen and progesterone receptor status: the multiethnic cohort study. Am J Epidemiol (2009) 2.14
The role of KRAS rs61764370 in invasive epithelial ovarian cancer: implications for clinical testing. Clin Cancer Res (2011) 2.09
Light at night and breast cancer risk among California teachers. Epidemiology (2014) 2.06
Regional variations in breast cancer among california teachers. Epidemiology (2004) 2.04
Hiatal hernia, reflux symptoms, body size, and risk of esophageal and gastric adenocarcinoma. Cancer (2003) 2.03
Study design: evaluating gene-environment interactions in the etiology of breast cancer - the WECARE study. Breast Cancer Res (2004) 2.03
Infertility, fertility drugs, and ovarian cancer: a pooled analysis of case-control studies. Am J Epidemiol (2002) 2.02
Effect of finasteride on serum levels of androstenedione, testosterone and their 5α-reduced metabolites in men at risk for prostate cancer. J Steroid Biochem Mol Biol (2013) 2.02
Type I and II endometrial cancers: have they different risk factors? J Clin Oncol (2013) 2.01
Changes in body fat and weight after a breast cancer diagnosis: influence of demographic, prognostic, and lifestyle factors. J Clin Oncol (2005) 2.01
Adolescent and adult soy intake and risk of breast cancer in Asian-Americans. Carcinogenesis (2002) 2.01
Non-Hodgkin lymphoma and obesity: a pooled analysis from the InterLymph Consortium. Int J Cancer (2008) 2.01
Predictors of the timing of natural menopause in the Multiethnic Cohort Study. Am J Epidemiol (2008) 2.01
Characteristics of triple-negative breast cancer in patients with a BRCA1 mutation: results from a population-based study of young women. J Clin Oncol (2011) 1.97
Pharmacokinetics of a combined oral contraceptive in obese and normal-weight women. Contraception (2010) 1.96
Rapidly rising breast cancer incidence rates among Asian-American women. Int J Cancer (2002) 1.95
Enhanced statistical tests for GWAS in admixed populations: assessment using African Americans from CARe and a Breast Cancer Consortium. PLoS Genet (2011) 1.94
Hair dye use, genetic variation in N-acetyltransferase 1 (NAT1) and 2 (NAT2), and risk of non-Hodgkin lymphoma. Carcinogenesis (2007) 1.94
Fruit and vegetable intake and risk of breast cancer by hormone receptor status. J Natl Cancer Inst (2013) 1.94
Estimated Asian adult soy protein and isoflavone intakes. Nutr Cancer (2006) 1.93
Serum high-density lipoprotein cholesterol, metabolic profile, and breast cancer risk. J Natl Cancer Inst (2004) 1.93
Tagging single nucleotide polymorphisms in cell cycle control genes and susceptibility to invasive epithelial ovarian cancer. Cancer Res (2007) 1.92
Radiation exposure, the ATM Gene, and contralateral breast cancer in the women's environmental cancer and radiation epidemiology study. J Natl Cancer Inst (2010) 1.91
A comprehensive haplotype analysis of CYP19 and breast cancer risk: the Multiethnic Cohort. Hum Mol Genet (2003) 1.88
Cigarette smoking and risk of non-Hodgkin lymphoma: a pooled analysis from the International Lymphoma Epidemiology Consortium (interlymph). Cancer Epidemiol Biomarkers Prev (2005) 1.87
Population-based study of the risk of second primary contralateral breast cancer associated with carrying a mutation in BRCA1 or BRCA2. J Clin Oncol (2010) 1.85
Possible socioeconomic and ethnic disparities in quality of life in a cohort of breast cancer survivors. Breast Cancer Res Treat (2007) 1.84
Does menopausal hormone replacement therapy interact with known factors to increase risk of breast cancer? J Clin Oncol (2002) 1.82
Genetic variation at the CYP19A1 locus predicts circulating estrogen levels but not breast cancer risk in postmenopausal women. Cancer Res (2007) 1.82
A meta-analysis identifies new loci associated with body mass index in individuals of African ancestry. Nat Genet (2013) 1.82
Hormonal factors and the risk of invasive ovarian cancer: a population-based case-control study. Fertil Steril (2004) 1.81
19p13.1 is a triple-negative-specific breast cancer susceptibility locus. Cancer Res (2012) 1.81
Fat, protein, and meat consumption and renal cell cancer risk: a pooled analysis of 13 prospective studies. J Natl Cancer Inst (2008) 1.81
Admixture mapping of 15,280 African Americans identifies obesity susceptibility loci on chromosomes 5 and X. PLoS Genet (2009) 1.81
Association of tamoxifen and uterine sarcoma. J Clin Oncol (2002) 1.80
Greatly increased occurrence of breast cancers in areas of mammographically dense tissue. Breast Cancer Res (2005) 1.76